That's what I mean. We already know the drug shows much promise What he had to answer honestly ( and did) was where the company stood with the FDA filings and responses, Uplisting, some degree of distant timelines, enrollments.. etc etc . In other words the CC was not groundbreaking news but rather time headwinds in getting anything done.